SUN PHARMACEUTICAL INDUSTRIES INC recalls Carbamazepine Tablets
- Recalling company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Product
- Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
- Reason
- CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Aug 3, 2026
- Reported
- Aug 26, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 1968 Bottles (1000Tablets/Bottle)
- Lot / codes
- Lot # AD94033, Exp Date: 5/31/2028.
- Company location
- Princeton, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0770-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0770-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.